Inflammation in pulmonary arterial hypertension
- PMID: 22215829
- DOI: 10.1378/chest.11-0793
Inflammation in pulmonary arterial hypertension
Abstract
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vascular remodeling of the precapillary pulmonary arteries, with excessive proliferation of vascular cells. Although the exact pathophysiology remains unknown, there is increasing evidence to suggest an important role for inflammation. Firstly, pathologic specimens from patients with PAH reveal an accumulation of perivascular inflammatory cells, including macrophages, dendritic cells, T and B lymphocytes, and mast cells. Secondly, circulating levels of certain cytokines and chemokines are elevated, and these may correlate with a worse clinical outcome. Thirdly, certain inflammatory conditions such as connective tissue diseases are associated with an increased incidence of PAH. Finally, treatment of the underlying inflammatory condition may alleviate the associated PAH. Underlying pathologic mechanisms are likely to be "multihit" and complex. For instance, the inflammatory response may be regulated by bone morphogenetic protein receptor type 2 (BMPR II) status, and, in turn, BMPR II expression can be altered by certain cytokines. Although antiinflammatory therapies have been effective in certain connective-tissue-disease-associated PAH, this approach is untested in idiopathic PAH (iPAH). The potential benefit of antiinflammatory therapies in iPAH is of importance and requires further study.
Similar articles
-
Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension.Adv Exp Med Biol. 2021;1303:275-303. doi: 10.1007/978-3-030-63046-1_15. Adv Exp Med Biol. 2021. PMID: 33788198
-
Single-Cell Imaging Maps Inflammatory Cell Subsets to Pulmonary Arterial Hypertension Vasculopathy.Am J Respir Crit Care Med. 2024 Jan 15;209(2):206-218. doi: 10.1164/rccm.202209-1761OC. Am J Respir Crit Care Med. 2024. PMID: 37934691
-
Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1559-1569. doi: 10.1161/ATVBAHA.117.309696. Epub 2017 Jun 15. Arterioscler Thromb Vasc Biol. 2017. PMID: 28619995 Free PMC article.
-
Dendritic Cell Subsets and Effector Function in Idiopathic and Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Front Immunol. 2019 Jan 22;10:11. doi: 10.3389/fimmu.2019.00011. eCollection 2019. Front Immunol. 2019. PMID: 30723471 Free PMC article. Review.
-
Perivascular Inflammation in Pulmonary Arterial Hypertension.Cells. 2020 Oct 22;9(11):2338. doi: 10.3390/cells9112338. Cells. 2020. PMID: 33105588 Free PMC article. Review.
Cited by
-
Serum Pentraxin 3 and hs-CRP Levels in Children with Severe Pulmonary Hypertension.Balkan Med J. 2014 Sep;31(3):219-23. doi: 10.5152/balkanmedj.2014.13307. Epub 2014 Sep 1. Balkan Med J. 2014. PMID: 25625020 Free PMC article.
-
High-mobility group box-1 induces vascular remodelling processes via c-Jun activation.J Cell Mol Med. 2015 May;19(5):1151-61. doi: 10.1111/jcmm.12519. Epub 2015 Feb 28. J Cell Mol Med. 2015. PMID: 25726846 Free PMC article.
-
Transfer of human hepatocyte growth factor reduces inflammation and prevents pulmonary arterial remodeling in monocrotaline-induced.Int J Clin Exp Pathol. 2014 Dec 1;7(12):8763-9. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674243 Free PMC article.
-
Right ventricular systolic pressure measurements in combination with harvest of lung and immune tissue samples in mice.J Vis Exp. 2013 Jan 16;(71):e50023. doi: 10.3791/50023. J Vis Exp. 2013. PMID: 23354416 Free PMC article.
-
Role of oxidized lipids in pulmonary arterial hypertension.Pulm Circ. 2016 Sep;6(3):261-73. doi: 10.1086/687293. Pulm Circ. 2016. PMID: 27683603 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
